Anne van Brussel

Anne van Brussel is an experienced Application Scientist at InnoSIGN since March 2022, specializing in mRNA-based OncoSIGNal pathway activity profiling technology for precision medicine. With a robust background in molecular biology, Anne accumulated over seven years at Philips, initially as a Research Engineer before transitioning through various roles, ultimately becoming a Research Scientist and technical lead for the OncoSignal product in the Molecular Pathway Diagnostics venture. Anne’s earlier experience includes internships at Maastricht University, Princess Margaret Hospital, and the University of Waikato, along with research roles focused on cell signaling and quality control. Anne holds a Master of Science in Clinical Molecular Sciences from Maastricht University and a Bachelor of Science in Life Sciences from Fontys Hogeschool Eindhoven.